Antitumor effects of anlotinib in thyroid cancer

There is no effective treatment for patients with poorly differentiated papillary thyroid cancer or anaplastic thyroid cancer (ATC). Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial. In this study, we aimed to better u...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Xianhui, Shi, Xianle, Dong, Qiman, Yu, Yang, Hou, Xiukun, Song, Xinhao, Wei, Xi, Chen, Lingyi, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215907/
https://www.ncbi.nlm.nih.gov/pubmed/30139768
http://dx.doi.org/10.1530/ERC-17-0558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215907/
https://www.ncbi.nlm.nih.gov/pubmed/30139768
http://dx.doi.org/10.1530/ERC-17-0558

Ejemplares similares